Category: Drug Discovery
Drug Discovery market research reports by DelveInsight
-
Dry Eye Disease - Pipeline Insight, 2025
DelveInsight’s, “Dry Eye Disease - Pipeline Insight, 2025” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Dry Eye Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Tie-2 Receptor Inhibitor - Pipeline Insight, 2025
“Tie-2 Receptor Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Tie-2 Receptor Inhibitor development. The report provides detailed coverage of the pipeline landscape for thi ... Read More
-
20s Proteasome Inhibitor - Pipeline Insight, 2025
“20s Proteasome Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 20s Proteasome Inhibitor development. The report provides detailed coverage of the pipeline landscape for thi ... Read More
-
30S Ribosomal Subunit (30S RNA) Inhibitor - Pipeline Insight, 2025
“30S Ribosomal Subunit (30S RNA) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 30S Ribosomal Subunit (30S RNA) Inhibitor development. The report provides detailed coverage ... Read More
-
5-HT1 Antagonist - Pipeline Insight, 2025
“5-HT1 Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT1 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More
-
5-HT1B Antagonist - Pipeline Insight, 2025
“5-HT1B Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT1B Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More
-
Adenosine A2 Receptor Antagonist - Pipeline Insight, 2025
“Adenosine A2 Receptor Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2 Receptor Antagonist development. The report provides detailed coverage of the pipeline l ... Read More
-
Alpha-1A Antagonist - Pipeline Insight, 2025
“Alpha-1A Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-1A Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Alpha-2 Agonist - Pipeline Insight, 2025
“Alpha-2 Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-2 Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of act ... Read More
-
Alpha-Amylase Inhibitor - Pipeline Insight, 2025
“Alpha-Amylase Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-Amylase Inhibitor development. The report provides detailed coverage of the pipeline landscape for this ... Read More
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2025
DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2025” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and non ... Read More
-
Angiotensin Modulators - Pipeline Insight, 2025
“Angiotensin Modulators - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin Modulators development. The report provides detailed coverage of the pipeline landscape for this me ... Read More
-
Arginine Depletors - Pipeline Insight, 2025
“Arginine Depletors - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Arginine Depletors development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2025
“Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Interleukin-1 (IL-1) Inhibitor development. The report provides detailed coverage of the pipeline lands ... Read More
-
Interleukin-4 (IL-4) Inhibitor - Pipeline Insight, 2025
“Interleukin-4 (IL-4) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Interleukin-4 (IL-4) Inhibitor development. The report provides detailed coverage of the pipeline lands ... Read More
-
Interleukin-8 (IL-8) Inhibitor - Pipeline Insight, 2025
“Interleukin-8 (IL-8) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Interleukin-8 (IL-8) Inhibitor development. The report provides detailed coverage of the pipeline lands ... Read More
-
Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025
“Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Kv1.3/1.5 Potassium Channel Blockers development. The report provides detailed coverage of the pi ... Read More
-
Inclusion Body Myositis- Pipeline Insight, 2025
DelveInsight’s, “Inclusion Body Myositis- Pipeline Insight, 2025” report provides comprehensive insights about 2+ companies and 3+ pipeline drugs in Inclusion Body Myositis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ... Read More
-
Advanced Melanoma - Pipeline Insight, 2025
DelveInsight’s, “Advanced Melanoma - Pipeline Insight, 2025” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Advanced Melanoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeu ... Read More
-
IgG4-Related Disease - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights IgG4-RD can affect virtually any organ, with common presentations including the pancreas, bile ducts, salivary glands, lacrimal glands, orbits, kidneys, lungs, and retroperitoneum. The true prevalence of IgG4-RD is unknown. Given its relatively recent discovery, lack of widespread rec ... Read More
-
Liver Cirrhosis - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights The Liver Cirrhosis market size in the 7MM was nearly USD 3,100 million in 2023, which is further anticipated to increase with a siginificant CAGR during the forecast period from (2024-2034). Liver cirrhosis is a chronic and progressive liver disease characterized by the replacement o ... Read More
-
Bullous Keratopathy - Market Insights, Epidemiology, and Market Forecast - 2034
Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 192 thousand diagnosed Bullous Keratopathy prevalent cases in the 7MM. Of these, the United States accounted for 41% of the cases, while Germany and Japan represented 13% and 9% of the cases, respectively. The bu ... Read More
-
Sickle Cell Disease (SCD) - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights Sickle cell disease (SCD) is a genetic blood disorder characterized by the presence of abnormal hemoglobin, causing red blood cells to become sickle-shaped. SCD is a global health concern, particularly prevalent in populations with African, Middle Eastern, Mediterranean, and South Asi ... Read More
-
Idiopathic Inflammatory Myositis - Market Insights, Epidemiology, and Market Forecast - 2034
Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 191,589 diagnosed prevalent cases of idiopathic inflammatory myositis in the 7MM. Of these, the United States accounted for 48% of the cases, while EU4 and the UK accounted for nearly 38% and Japan represented 14 ... Read More
-
Ulcerative Colitis - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights The Ulcerative Colitis Market Size in the 7MM was around USD 8,400 Million in 2023. The Ulcerative Colitis Market is anticipated to witness a positive shift owing to better uptake of existing drugs, and raised awareness. Ulcerative Colitis treatment is complex and comprises the use of ... Read More
Research Assistance
